Augmenix Announced Clearance Of Its SpaceOAR System For Prostate Cancer

Augmenix Announced Clearance Of Its SpaceOAR System For Prostate Cancer
Augmenix, Inc. recently announced that the FDA has approved the SpaceOAR System, the first product in the US receiving clearance as a spacer that protects the rectum in men undergoing prostate cancer (PCa) radiotherapy. Many advancements have been achieved in PCa radiotherapy, however, because of the prostate-rectum proximity, it is hard to deliver radiation properly to the prostate without harming the rectum,

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , .

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

Leave a Comment

Your email address will not be published. Required fields are marked *